Dr. Nicholas Blondin, MD
Claim this profileYale University
Studies Brain Tumor
Studies Glioblastoma
7 reported clinical trials
18 drugs studied
Area of expertise
1Brain Tumor
IDH positive
1p/19q co-deletion positive
H3 K27M positive
2Glioblastoma
Affiliated Hospitals
Clinical Trials Nicholas Blondin, MD is currently running
Multiple Therapies
for Glioblastoma
This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.
Recruiting1 award Phase 2 & 310 criteria
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3
More about Nicholas Blondin, MD
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Nicholas Blondin, MD has experience with
- Temozolomide
- ONC201
- Clinical Observation
- Radiation Therapy
- CCNU
- Radiotherapy
Breakdown of trials Nicholas Blondin, MD has run
Brain Tumor
Glioblastoma
Mesial Temporal Sclerosis
Nervous System Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nicholas Blondin, MD specialize in?
Nicholas Blondin, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are 1p/19q co-deletion positive.
Is Nicholas Blondin, MD currently recruiting for clinical trials?
Yes, Nicholas Blondin, MD is currently recruiting for 5 clinical trials in Fairfield Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Nicholas Blondin, MD has studied deeply?
Yes, Nicholas Blondin, MD has studied treatments such as Temozolomide, ONC201, Clinical Observation.
What is the best way to schedule an appointment with Nicholas Blondin, MD?
Apply for one of the trials that Nicholas Blondin, MD is conducting.
What is the office address of Nicholas Blondin, MD?
The office of Nicholas Blondin, MD is located at: Yale University, Fairfield, Connecticut 06824 United States. This is the address for their practice at the Yale University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.